#VisualAbstract: Combination of spartalizumab plus dabrafenib and trametinib does not significantly improve survival in BRAFV600-mutated metastatic melanoma Jul 28, 2022 Click to read this study in the Journal of Clinical Oncology. Author admin View all posts
